Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 242

1.

Different treatment settings of Granulocyte-Colony Stimulating Factor and their impact on T cell-specific immune response in experimental stroke.

Dietel B, Cicha I, Achenbach S, Kollmar R, Garlichs C, Tauchi M.

Immunol Lett. 2014 Mar-Apr;158(1-2):95-100. doi: 10.1016/j.imlet.2013.12.006. Epub 2013 Dec 12.

PMID:
24333341
2.

Suppression of dendritic cell functions contributes to the anti-inflammatory action of granulocyte-colony stimulating factor in experimental stroke.

Dietel B, Cicha I, Kallmünzer B, Tauchi M, Yilmaz A, Daniel WG, Schwab S, Garlichs CD, Kollmar R.

Exp Neurol. 2012 Oct;237(2):379-87. doi: 10.1016/j.expneurol.2012.06.019. Epub 2012 Jun 27.

PMID:
22750328
3.
4.

An extended window of opportunity for G-CSF treatment in cerebral ischemia.

Schneider A, Wysocki R, Pitzer C, Krüger C, Laage R, Schwab S, Bach A, Schäbitz WR.

BMC Biol. 2006 Oct 18;4:36.

5.

Strategies to improve post-stroke behavioral recovery in aged subjects.

Buga AM, Bălşeanu A, Popa-Wagner A, Mogoantă L.

Rom J Morphol Embryol. 2009;50(4):559-82.

6.

Decreased focal inflammatory response by G-CSF may improve stroke outcome after transient middle cerebral artery occlusion in rats.

Sehara Y, Hayashi T, Deguchi K, Zhang H, Tsuchiya A, Yamashita T, Lukic V, Nagai M, Kamiya T, Abe K.

J Neurosci Res. 2007 Aug 1;85(10):2167-74.

PMID:
17497673
7.

Granulocyte-colony stimulating factor in combination with stem cell factor confers greater neuroprotection after hypoxic-ischemic brain damage in the neonatal rats than a solitary treatment.

Doycheva D, Shih G, Chen H, Applegate R, Zhang JH, Tang J.

Transl Stroke Res. 2013 Apr;4(2):171-8. doi: 10.1007/s12975-012-0225-2. Epub 2012 Nov 8.

8.

In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke.

Petty MA, Neumann-Haefelin C, Kalisch J, Sarhan S, Wettstein JG, Juretschke HP.

Eur J Pharmacol. 2003 Aug 1;474(1):53-62.

PMID:
12909195
9.

Suppressive effects of intrathecal granulocyte colony-stimulating factor on excessive release of excitatory amino acids in the spinal cerebrospinal fluid of rats with cord ischemia: role of glutamate transporters.

Chen WF, Sung CS, Jean YH, Su TM, Wang HC, Ho JT, Huang SY, Lin CS, Wen ZH.

Neuroscience. 2010 Feb 17;165(4):1217-32. doi: 10.1016/j.neuroscience.2009.11.033. Epub 2009 Nov 22.

PMID:
19932886
10.

Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia.

Schäbitz WR, Kollmar R, Schwaninger M, Juettler E, Bardutzky J, Schölzke MN, Sommer C, Schwab S.

Stroke. 2003 Mar;34(3):745-51. Epub 2003 Feb 13.

PMID:
12624302
11.

Anti-neutrophil antibody enhances the neuroprotective effects of G-CSF by decreasing number of neutrophils in hypoxic ischemic neonatal rat model.

Doycheva DM, Hadley T, Li L, Applegate RL 2nd, Zhang JH, Tang J.

Neurobiol Dis. 2014 Sep;69:192-9. doi: 10.1016/j.nbd.2014.05.024. Epub 2014 May 27.

12.

Impact of the neutrophil response to granulocyte colony-stimulating factor on the risk of hemorrhage when used in combination with tissue plasminogen activator during the acute phase of experimental stroke.

Gautier S, Ouk T, Tagzirt M, Lefebvre C, Laprais M, Pétrault O, Dupont A, Leys D, Bordet R.

J Neuroinflammation. 2014 May 27;11:96. doi: 10.1186/1742-2094-11-96.

13.

Granulocyte colony-stimulating factor does not promote neurogenesis after experimental intracerebral haemorrhage.

Kallmünzer B, Tauchi M, Schlachetzki JC, Machold K, Schmidt A, Winkler J, Schwab S, Kollmar R.

Int J Stroke. 2014 Aug;9(6):783-8. doi: 10.1111/ijs.12217. Epub 2013 Dec 19.

PMID:
24920160
14.

Granulocyte colony-stimulating factor protects the brain against experimental stroke via inhibition of apoptosis and inflammation.

Solaroglu I, Cahill J, Tsubokawa T, Beskonakli E, Zhang JH.

Neurol Res. 2009 Mar;31(2):167-72. doi: 10.1179/174313209X393582.

PMID:
19298757
15.
16.

Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke.

Sevimli S, Diederich K, Strecker JK, Schilling M, Klocke R, Nikol S, Kirsch F, Schneider A, Schäbitz WR.

Exp Neurol. 2009 Jun;217(2):328-35. doi: 10.1016/j.expneurol.2009.03.018. Epub 2009 Mar 28.

PMID:
19332060
17.

Granulocyte-colony stimulating factor delays PWI/DWI mismatch evolution and reduces final infarct volume in permanent-suture and embolic focal cerebral ischemia models in the rat.

Bråtane BT, Bouley J, Schneider A, Bastan B, Henninger N, Fisher M.

Stroke. 2009 Sep;40(9):3102-6. doi: 10.1161/STROKEAHA.109.553958. Epub 2009 Jul 30.

PMID:
19644069
18.

A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).

Schäbitz WR, Krüger C, Pitzer C, Weber D, Laage R, Gassler N, Aronowski J, Mier W, Kirsch F, Dittgen T, Bach A, Sommer C, Schneider A.

J Cereb Blood Flow Metab. 2008 Jan;28(1):29-43. Epub 2007 Apr 25.

PMID:
17457367
19.

Intranasal Delivery of Granulocyte Colony-Stimulating Factor Enhances Its Neuroprotective Effects Against Ischemic Brain Injury in Rats.

Sun BL, He MQ, Han XY, Sun JY, Yang MF, Yuan H, Fan CD, Zhang S, Mao LL, Li DW, Zhang ZY, Zheng CB, Yang XY, Li YV, Stetler RA, Chen J, Zhang F.

Mol Neurobiol. 2016 Jan;53(1):320-330. doi: 10.1007/s12035-014-8984-2. Epub 2014 Nov 29.

PMID:
25432887
20.

Cocaine-and amphetamine-regulated transcript modulates peripheral immunity and protects against brain injury in experimental stroke.

Chang L, Chen Y, Li J, Liu Z, Wang Z, Chen J, Cao W, Xu Y.

Brain Behav Immun. 2011 Feb;25(2):260-9. doi: 10.1016/j.bbi.2010.09.017. Epub 2010 Sep 30.

PMID:
20869431

Supplemental Content

Support Center